Short Commentary - (2016) Volume 4, Issue 6

Utility of the Red Blood Cell-Derived Microparticles as a Marker of Periprocedural Adverse Effects amongst Patients with Acute ST-Segment Elevation Myocardial Infarction

Alexander E Berezin1,2*
1Therapeutic Unit, Private Hospital “Vita-Center”, Zaporozhye, Ukraine
2Department of Internal Medicine, Therapeutic Unit, Medical University, Zaporozhye, Ukraine
*Corresponding Author: